Daré Bioscience, Inc.
DARE
$1.85
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.44M | -3.56M | -4.02M | -4.38M | -5.51M |
| Total Depreciation and Amortization | 534.40K | 481.90K | 460.10K | 158.10K | 6.40K |
| Total Amortization of Deferred Charges | -135.90K | 124.30K | -5.90K | 17.50K | -21.90K |
| Total Other Non-Cash Items | 384.80K | 596.10K | 620.70K | 488.10K | 735.10K |
| Change in Net Operating Assets | 2.10M | 1.92M | -2.48M | -1.76M | 10.09M |
| Cash from Operations | 1.44M | -442.10K | -5.42M | -5.47M | 5.31M |
| Capital Expenditure | -206.60K | -174.70K | 153.40K | -157.30K | -562.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -206.60K | -174.70K | 153.40K | -157.30K | -562.80K |
| Total Debt Issued | 0.00 | 486.70K | -- | -- | 0.00 |
| Total Debt Repaid | -529.00K | -580.50K | -521.30K | -187.20K | -187.20K |
| Issuance of Common Stock | 1.27M | 18.74M | 475.00K | 436.20K | 55.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -321.70K | -- | 2.50K | -2.50K | -79.60K |
| Cash from Financing | 424.10K | 18.65M | -43.80K | 246.60K | -211.30K |
| Foreign Exchange rate Adjustments | -25.70K | 6.90K | 12.90K | 13.10K | -66.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.64M | 18.04M | -5.30M | -5.37M | 4.47M |